¿ì¸®ÀÇ ºÐ¼® ¼ºñ½º ÆÀÀº ¾ö°ÝÇÑ cGMP¿Í ICH complianceÇÏ¿¡¼ ÀÛ¾÷ÇÑ´Ù.
+ Classes of Molecules (ºÐÀÚÀÇ ºÐ·ù)
- Peptides, proteins, and glycoproteins (ÆéŸÀ̵å, ´Ü¹éÁú, ´ç´Ü¹éÁú)
- Small molecules (¼ÒÇü ºÐÀÚ)
- Carbohydrates (ź¼öȹ°)
- Lipids and glycolipids (ÁöÁú, ´çÁöÁú)
- Natural products (õ¿¬ Á¦Ç°)
- Oligonucleotides (¿Ã¸®°í´ºÅ¬·¹¿ÀŸÀ̵å)
+ Analytical Services (ºÐ¼® ¼ºñ½º)
- Method development and validation (¹æ¹ý °³¹ß ¹× À¯È¿¼º)
- Drug substance characterization (¾à¹° substance Ư¼º)
- Reference standard certification (Âü°í ±âÁØ certification)
- Drug substance and product lot release (¾à¹°°ú Á¦Ç° ·ÎÆ® ÆÇ¸Å)
- Process validation/cleaning validation sample analysis (ÀýÂ÷ÀÇ À¯È¿¼º/ Ŭ¸®´× À¯È¿¼º »ùÇà ºÐ¼®)
- Product compatibility studies (Á¦Ç° ÀûÇÕ¼º ¿¬±¸)
- Residual solvent analysis (ÀÜ¿© ¿ë¸Å ºÐ¼®)
- Immunoassays (¸é¿ª½ÃÇè)
+ Protein Characterization (´Ü¹éÁú Ư¼º)
ÇöÀçÀÇ FDA°¡À̵å¶óÀο¡ µû¸£¸é, ºÐÀÚÀÇ ±¤¹üÀ§ÇÑ ºÐ¼®Àº Àß ¹¦»çµÈ »ý¹°ÇÐÀ» È®¸³ÇÒ Çʿ䰡 ÀÖ´Ù. ´Ü¹éÁúÀÇ Æ¯¼º ¹× ±¸Á¶ ¼³¸íÀÇ ºÐ¾ß¿¡¼ ¼÷·ÃµÈ Àü¹®±â¼ú°ú Áö½ÄÀ» ¼ÒÀ¯ÇÑ ¿ì¸®ÀÇ ¼÷·ÃµÈ °úÇÐÀڵ鿡 ÀÇÇØ º¸¿ÏµÇ´Â ÁÖµÈ ¿ì¼¼ ±â¼ú°ú ±â±¸¸¦
ÀÌ¿ëÇÑ´Ù.
+ Protein Chemistry Services (´Ü¹éÁú ÈÇÐ ¼ºñ½º)
- Amino acid composition analysis (¾Æ¹Ì³ë»ê ÇÕ¼º ºÐ¼®)
- N- and C-terminal sequencing (N- °ú C-¸»´Ü sequencing)
- SDS-PAGE coupled to laser densitometry (·¹ÀÌÁ® ¹Ðµµ°èÃø±â¿Í ¿¬°áµÈ SDS-PAGE)
- IEF coupled to laser densitometry (Å« ³óµµ°èÃø±â¿Í ¿¬°áµÈ IEF)
- Western blot (¿þ½ºÅÏ ºí·µ)
- SEC-HPLC for aggregation analysis (Áý´Ü ºÐ¼®À» À§ÇÑ SEC-HPLC)
- RP-HPLC for protein analysis (´Ü¹éÁú ºÐ¼®À» À§ÇÑ RP-HPLC)
- Peptide mapping by LC-MS (LC-MS¿¡ ÀÇÇÑ ÆéƼµå Á¦ÀÛ)
- Monosaccharide composition (´Ü´ç·ù Á¶¼º)
- Glycosylation/sulfation/phosphorylation site identification (Glycosylation/ Ȳ»êÈ/ ÀλêÈ ºÎÀ§ µ¿ÀÏÈ)
- Site-specific oligosaccharide profiling (ºÎÀ§º° ƯÁ¤ ¿Ã¸®°í»çÄ«¶óÀÌµå ºÐ¼®Ç¥)
- Disulfide bond pattern determination (ÀÌȲȹ° °áÇÕÀ¯Çü °áÁ¤)
- Mass spectrometry of proteins (´Ü¹éÁúÀÇ Áú·®ºÐ±¤°è)
- Analysis of host cell proteins and other cell culture contaminants (ELISA) (¼÷ÁÖ¼¼Æ÷ ´Ü¹éÁú°ú ´Ù¸¥ ¼¼Æ÷ÇÔÀ¯¹°ÀÇ ºÐ¼®)
- ELISA method development and validation (ELASA ¹æ¹ý°³¹ß ¹× À¯È¿¼º)
+ Release and In-Process Testing (ÆÇ¸Å ¹× °¡°ø 󸮽ÃÇè)
ÀÏ»óÀûÀ¸·Î ÆÇ¸Å »óǰÀ» ÅëÇØ ÃÖÁ¾ ÀüÀÓ»ó Á¦Ç°, ¿ø·á¹°Áú, ¹úÅ©¾à¹° ÀÇ ÃÑüÀûÀÎ ºÐ¼®À» ½ÃÇàÇÑ´Ù.
À̰ÍÀº ¾Æ·¡ÀÇ ¹æ¹ýÀ» Æ÷ÇÔÇÑ´Ù. :
- Process contaminants (°¡°ø ÇÔÀ¯¹°)
- Residual solvents (ÀÜ¿© ¿ë¸Å)
- Excipients (Excipients)
- Impurities (ºÒ¼ø¹°)
- Activity (Ȱ¼º)
- Potency (È¿´É)
- Identity (µ¶ÀÚ¼º)
+ Stability Programs (¾ÈÁ¤¼º ÇÁ·Î±×·¥)
ÀÇ·ÚÀο¡°Ô ¾à¹°, Á¦Ç° Æò°¡, ÀÓ»óÁ¦Ç° °ø±Þ ¹× ÁÖ¹® ¿Ï¼ºµÈ Á¦Ç°¿¡ ´ëÇÑ Æ÷°ýÀûÀÎ ¾ÈÁ¤¼º ÇÁ·Î±×·¥À» Á¦°øÇÑ´Ù. ¿ì¸®ÀÇ ºÐ¼® ¹× ¾ÈÁ¤¼º ÆÀÀº ¿Ïº®ÇÑ ºÐ¼®Áö¿øÀ» °ø±ÞÇϸç ÀÇ·ÚÀÎÀÇ ½Ã¹æ¼¿¡ ´ëÇÑ ÇÁ·Î±×·¥À» ¸ÂÃçÁÙ °ÍÀ̸ç, ½ÉÁö¾î ±×µéÀÇ ¿ä±¸¿¡ ÀÇÁ¸ÇÏ´Â Æ÷°ýÀûÀÎ
°³¹ß ÆÐŰÁö¸¦ °í¾ÈÇÒ °ÍÀÌ´Ù. ¿ì¸®ÀÇ ½Ã¼³Àº °¢°¢ ¿Ïº®ÇÑ FDA¿Í ICHÀÇ ¿ä±¸´ë·Î ¿òÁ÷ÀÌ´Â ±× ÀÚ¸®¿¡¼ ¹Ù·Î µÇµ¹¾Æ¿À´Â ÀÀ±Þ ÆÄ¿ö »ý¼º°ú ¿ÏÀüÈ÷ ÀÎÁõµÈ Rees¢ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ¸·Î µ¶¸³ÀûÀ¸·Î Á¦¾îµÇ°í ÅëÁ¦µÇ´Â ÃÖ»óÀÇ ¾ÈÁ¤¼º ½Ã¼³À» °®Ãß¾ú´Ù.
+ Stability Services (¾ÈÁ¤¼º ¼ºñ½º)
- Controlled and monitored storage facilities (ÅëÁ¦µÇ°í ¸ð´ÏÅÍ µÇ´Â â°í ½Ã¼³)
- Accelerated/thermal, freeze/thaw cycling
- Program design and management (ÇÁ·Î±×·¥ °í¾È°ú ¿î¿µ)
-¡¤Protocol development (½ÃÇè¹æ¹ý °³¹ß)
- Customized report generation (ÁÖ¹® º¸°í¼ ¹ß»ý)
- Guaranteed on-time testing (º¸Áõ µÈ Á¤È®ÇÑ ½ÃÇè)
- Complete analytical and formulations support (¿ÏÀüÇÑ ºÐ¼® ¹× Á¦Ç° Áö¿ø) |